BIOTECH, OPTIONS, STOCKS, TRADING

Adam Johnson

Founder,

BullseyeBrief.com

  • Founder of BullseyeBrief.com
  • Previous Host on Bloomberg TV
  • Graduate from Princeton

About Adam

Adam Johnson is the founder of BullseyeBrief.com, an investment letter which explores American Ingenuity through actionable stock picks. Previously he anchored several daily programs at Bloomberg TV, interviewing CEOs, heads of state, and prominent investors. Mr. Johnson also traded stocks, options, and oil at ING Asset Management, Louis Dreyfus, and Merrill Lynch. He graduated from Princeton with a BA in economics.

Adam's Articles

After ten years of privately funded development, electric-powered flight capable of lifting several thousand pounds is now a reality, notes Adam Johnson, a leading growth stock expert and editor of Bullseye Brief.
Covid has catapulted remote medical care from an experimental lifeline serving rural communities, to a mainstream methodology strengthening national hospital systems, observes Adam Johnson, growth stock expert and editor of Bullseye Brief.
I focus on a portfolio of dynamic, US companies propelling the world forward across multiple industries. Every pick shares three defining attributes: great story, compelling data, newsy catalyst, notes Adam Johnson, editor of Bullseye Brief.
Progenity (PROG) is a diagnostic testing company focused primarily on women’s health, explains Adam Johnson, growth stock expert and editor of Bullseye Brief.

Adam's Videos

How we move is changing fast and it's not about building a faster Tesla. 30-ft drones transport US Air Force personnel across sprawling bases. Fuel cells power construction equipment, lifting thousands of pounds. Electric delivery vans make UPS greener and our air cleaner. Several pioneering companies are propelling the world forward at record speed. The question is which ones to buy today? Join Adam Johnson to discover how the future of mobility is now.
SpaceX made history with the launch into orbit of the first manned space capsule by a private company. While we may not be vacationing in Mars any time soon, we are living in a world where technology is evolving faster than ever. In this panel discussion, get up to speed on the latest trends in the industry, explore breakthrough technologies, and hear about the most innovative disruptors reshaping the future.
Tune in to this 30-minute session to discuss several Med-Tech hybrid companies as case studies, explaining how they're redefining health and moving the world forward. Adam Johnson is long on all of them, and see's significant upside. "Health Care's Holy Grail" is his biggest investment theme for 2021, thanks to the convergence of wearables, AI, 5G, and telemedicine, and he's excited to share with you what he has learned!
Biotechnology offers significant upside if you know where to look. Adam Johnson, founder of BullseyeBrief.com, shares his three favorite biotech stocks under $3, why he's long and what he expects. These are some of the best examples of American Ingenuity!